Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/25/2003US6653297 Synergistic treatment with progestationally active material; reducing side effects
11/25/2003US6653296 Antiretroviral enantiomeric nucleotide analogs
11/25/2003US6653294 Antiinflammatory agents
11/25/2003US6653293 Administering substance stimulating infected cells to increase HIV replication; causing extracorporeal apoptosis and reinfusing blood
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653290 Tumor proliferation inhibitors
11/25/2003US6653289 Anticancer drugs; reduced side effects
11/25/2003US6653288 Combined with hormonal growth promoter dissolved in polymer free solvent; promoting animal growth and inhibiting parasitic infection/ infestation
11/25/2003US6653283 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
11/25/2003US6653278 Selenium-containing pro-drugs for cancer therapy
11/25/2003US6653133 Antisense modulation of Fas mediated signaling
11/25/2003US6653125 Synthetic hepatitis C genes
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/25/2003US6652891 Vegetable oil, emulsifier and plant extract
11/25/2003US6652890 Treating cancer cells that express a membrane protein tNOX, a hormone-insensitive and drug-responsive form of NOX (NADH oxidase) specific to cancer cells
11/25/2003US6652884 Method for the treatment of solid tumors by albumin microparticles incorporating paclitaxel
11/25/2003US6652882 Containing uncrosslinked polymer, crosslinked insoluble polymer or mixture
11/25/2003US6652881 Micronized, quick dissolving; water, polysorbate 80 and sodium lauryl sulfate
11/25/2003US6652877 With lipid or liposomal compounds
11/25/2003US6652876 Active substance patch, kind to the skin, for transdermal administration of nonsteroidal antirheumatics
11/25/2003US6652874 Pharmaceutical preparations and methods for their regional administration
11/25/2003US6652873 Compositions and methods for enhancing receptor-mediated cellular internalization
11/25/2003US6652866 Method for treating diseases of fungal, yeast, and prion protein etiology
11/25/2003US6652865 For decreasing the effect of intestinal metabolism on a drug
11/25/2003US6652858 Administering an OX-2 protein or a nucleic acid encoding it to preventing graft rejection, fetal loss, autoimmune disease, and allergies; immunosuppressants; gene therapy
11/25/2003US6652840 Aluminum chloride, ferric sulfate, regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and solvent; easy to use; reducing heart rate stimulation, staining, acid irritations and adhesive interference
11/25/2003US6652838 Method for treating diabetes mellitus
11/25/2003US6652837 Preparation of novel particles for inhalation
11/25/2003US6652534 Apparatus and method for determining implant size
11/25/2003US6652527 Supplemental spine fixation device and method
11/25/2003CA2258811C Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/25/2003CA2163028C New thiazolidinediones and pharmaceutical agents containing them
11/25/2003CA2134679C Soluble analogs of probucol
11/25/2003CA2119145C Ferrite particles and therapeutic and diagnostic uses therefore
11/25/2003CA2117305C Substituted imidazole derivatives and their preparation and use
11/25/2003CA2106370C Antibiotic compounds
11/25/2003CA2105014C Imidazolidine derivatives
11/25/2003CA2080820C Azo-derivatives, pharmaceutical preparations containing them, and their uses
11/25/2003CA2076028C Compositions and methods of treatment of sympathetically maintained pain
11/22/2003WO2005032452A2 Alkyl-substituted pcdf as a treatment for prostate cancer
11/22/2003CA2497877A1 Alkyl pcdf as a treatment for prostate cancer
11/22/2003CA2429387A1 Compositions for providing vitamin d year round and uses thereof
11/21/2003CA2428112A1 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
11/20/2003WO2003095971A2 Posh nucleic acids, polypeptides and related methods
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095667A2 Autoimmune conditions and nadph oxidase defects
11/20/2003WO2003095665A2 Pmea and pmpa cyclic producing synthesis
11/20/2003WO2003095626A2 Purified composition of bispecific molecules and methods of production
11/20/2003WO2003095625A2 Method for cytoprotection through mdm2 and hdm2 inhibition
11/20/2003WO2003095621A2 Apoptotic ebv-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferactive disorder
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095498A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003WO2003095471A2 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
11/20/2003WO2003095470A1 Platinum complexes having antitumor activity
11/20/2003WO2003095461A1 Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds
11/20/2003WO2003095460A1 Cascade esters of camptothecins and methods of treating cancer using these compounds
11/20/2003WO2003095457A1 Adenosine a3 receptor modulators
11/20/2003WO2003095455A2 Substituted pyrazolopyrimidines
11/20/2003WO2003095453A1 Compounds against helicobacter activity
11/20/2003WO2003095452A1 Substituted pyrroline kinase inhibitors
11/20/2003WO2003095451A1 Carbamate-substituted pyrazolopyridines
11/20/2003WO2003095447A1 Process for the preparation of a hydrate of an anthranilic acid derivative
11/20/2003WO2003095438A1 Substituted phenylacetamides and their use as glucokinase activators
11/20/2003WO2003095437A1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent
11/20/2003WO2003095436A1 Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use
11/20/2003WO2003095435A1 Amide derivatives
11/20/2003WO2003095434A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003WO2003095432A1 Benzimidazole derivatives
11/20/2003WO2003095428A1 Dopamine receptor modulators as antipsychotic agents
11/20/2003WO2003095426A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions
11/20/2003WO2003095424A1 Process for producing shogaol and intermediates for the synthesis thereof
11/20/2003WO2003095421A1 Amino acid analogues
11/20/2003WO2003095420A1 Hydroxy tetrahydro-naphthalenylurea derivatives
11/20/2003WO2003095412A1 2-(α-HYDROXYPENTYL) BENZOATE AND ITS PREPARATION AND USE
11/20/2003WO2003095404A1 Cembranoids with chemopreventive activity
11/20/2003WO2003095403A1 Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity
11/20/2003WO2003095029A1 Bisphosphonic acid for the treatment and prevention of osteoporosis
11/20/2003WO2003095011A1 Medicament respiratory delivery device and cartridge
11/20/2003WO2003094995A1 Method and device for controlling drug pharmacokinetics
11/20/2003WO2003094991A1 Medical products comprising a haemocompatible coating, production and use thereof
11/20/2003WO2003094990A1 Compounds and method for coating surfaces in a haemocompatible manner
11/20/2003WO2003094979A1 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
11/20/2003WO2003094969A1 Methods and compositions for treating tinea versicolor using combinations of retinoids and certain antifungals
11/20/2003WO2003094968A2 Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
11/20/2003WO2003094965A2 Modulation of neural stem cells with s1p or lpa receptor agonists
11/20/2003WO2003094957A2 Methods of therapy for inducing tolerance
11/20/2003WO2003094954A1 Composition and method for minimizing or avoiding adverse effects of vesicants
11/20/2003WO2003094952A1 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/20/2003WO2003094951A1 Soluble formulations comprising insulin aspart and insulin detemir
11/20/2003WO2003094950A2 A method of inhibiting the emigration of cells from the intravascular compartment into tissues
11/20/2003WO2003094946A1 Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid
11/20/2003WO2003094944A1 Formulations useful in the treatment of male and female impotence
11/20/2003WO2003094943A1 Formulations useful in the treatment of male and female impotence
11/20/2003WO2003094934A1 Medicine for prevention of and treatment for amyloidosis
11/20/2003WO2003094931A1 Pharmaceutical compositions with anti-tumour activity, in particular for the treatment of leukaemia and glioblastomas
11/20/2003WO2003094930A1 Embolization using degradable crosslinked hydrogels
11/20/2003WO2003094929A2 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
11/20/2003WO2003094928A1 Pharmaceutical compositions for lowering blood glucose and blood cholesterol levels
11/20/2003WO2003094927A1 Method of inhibiting d-glucose absorption and d-glucose absorption inhibitor
1 ... 5267 5268 5269 5270 5271 5272 5273 5274 5275 5276 5277 5278 5279 5280 5281 5282 5283 5284 5285 5286 5287 ... 7860